In Nigeria, access to US-guided breast biopsy within 120 minutes ranges from 49.0% to 77.1% between northern and southern regions.
Nigeriacancer du seinpublié 2023JCO global oncologyPubMeddocument de 7 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
381 evidences · page 16 / 16
In Nigeria, access to US-guided breast biopsy within 120 minutes ranges from 49.0% to 77.1% between northern and southern regions.
Nigeriacancer du seinpublié 2023JCO global oncologyPubMeddocument de 7 observations
83 %83% of the tumors were high-grade.
Nigeriacancer du seinpublié 2009Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument de 12 observationsDOI 10.1200/jco.2008.19.6873
70,2 %70.2% of respondents were married in a study of breast cancer patients at University College Hospital, Ibadan, Nigeria.
Nigeriacancer du seinobservé 2018publié 2019Journal of global oncologyPubMeddocument de 9 observations
65,92 %Europeans showed the highest rs799917 G allele frequency at 65.92%.
Nigeriacancer du seinpublié 2026Cancer control : journal of the Moffitt Cancer CenterPubMeddocument de 7 observations
0,38 AORWomen in the uppermost category of household physical activity had an adjusted odds ratio of 0.38 for breast cancer risk.
Nigeriacancer du seinpublié 2022Cancer epidemiologyPubMeddocument de 6 observations
0,44 AORWomen in the upper middle category of total physical activity had an adjusted odds ratio of 0.44 for breast cancer risk.
Nigeriacancer du seinpublié 2022Cancer epidemiologyPubMeddocument de 6 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.